Bradley Foster & Sargent Inc. CT Decreases Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Bradley Foster & Sargent Inc. CT reduced its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 23.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 36,496 shares of the company’s stock after selling 11,430 shares during the quarter. Bradley Foster & Sargent Inc. CT’s holdings in Privia Health Group were worth $713,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. FMR LLC lifted its holdings in Privia Health Group by 1.5% in the 3rd quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after buying an additional 271,645 shares in the last quarter. Riverbridge Partners LLC increased its position in shares of Privia Health Group by 19.7% during the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock worth $113,868,000 after acquiring an additional 958,418 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Privia Health Group by 1.0% in the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock worth $43,986,000 after acquiring an additional 23,178 shares in the last quarter. Franklin Resources Inc. boosted its holdings in Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after purchasing an additional 28,480 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Privia Health Group by 6.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,064,224 shares of the company’s stock valued at $19,380,000 after purchasing an additional 65,152 shares during the last quarter. 94.48% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Stephens restated an “overweight” rating and set a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. Barclays upped their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a report on Friday, November 8th. JMP Securities reiterated a “market outperform” rating and set a $26.00 price objective on shares of Privia Health Group in a research note on Friday, February 14th. Truist Financial boosted their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Finally, JPMorgan Chase & Co. increased their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Friday, November 29th. One analyst has rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Privia Health Group currently has a consensus rating of “Buy” and an average price target of $25.18.

Privia Health Group Stock Down 0.5 %

Shares of PRVA stock opened at $24.52 on Friday. The company has a market cap of $2.94 billion, a P/E ratio of 245.22, a PEG ratio of 3.47 and a beta of 0.87. The business has a 50 day moving average of $21.99 and a two-hundred day moving average of $20.40. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $25.67.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.